| INVO Bioscience is a medical device company. Co.'s focus is the manufacture and sale of the INVOcell device and the INVO technology to provide an alternative infertility treatment. The INVOcell device is used for the incubation of eggs and sperm during fertilization and early embryo development. The INVOcell utilizes the women's vagina as an incubator to support a fertilization and embryo development environment, and infertility treatment. The INVOcell system consists of: INVOcell Culture Device, which is used in preparing, holding, and transferring human gametes or embryos; and INVOcell Retention Device, which is used to aid in retention of the INVOcell Device in the vaginal cavity. We show 2 historical shares outstanding datapoints in our INVO shares outstanding history coverage, used to compute INVO market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing INVO market cap history over the course of time is important for investors
interested in comparing INVO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of INVO versus a peer is one thing; comparing
INVO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like INVO can fluctuate over the course of history.
With this page we aim to empower investors researching INVO by allowing them to research the INVO market cap history.